We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$527K
AUM Growth
-$23.6K
Cap. Flow
+$1.12K
Cap. Flow %
0.21%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Avg Time Held
2 quarters
Top 10 Avg Time Held
2 quarters
Top 20 Avg Time Held
2 quarters

Top Buys

Rank Stock Value
1
KRSA
Korsana Biosciences, Inc. Common Stock
KRSA
+$1.12K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KRSA
1
Korsana Biosciences, Inc. Common Stock
KRSA
$1.54B
$527K 100%
23,540
+50
+0.2% +$1.12K
2023 Q3
2 quarters

Similar funds

CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return

Tyndall Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Tyndall Capital Partners held 1 position worth $527K, down 4.3% from $551K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners added most to Korsana Biosciences, Inc. Common Stock in Q1 2024, an estimated $1.12K increase.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $527K portfolio in Q1 2024.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q1 2024.
  • Tyndall Capital Partners's portfolio value fell 4.3% quarter-over-quarter to $527K.

Based on Tyndall Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.